DERISQ
Live / Applied — Final refusal maintained — action continuing final mailed (as of 18 Mar 2026)
What this means for you
Not registered yet, but its 07 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99325158
- Mark type
- Stylized text
- Filed
- 07 Aug 2025
Goods and services
- Class 042 — Scientific and technological services: Chemical analysis services; Use of proprietary artificial intelligence on a contract basis with customers to analyze drug molecules using genomic and other biological data with respect to the likelihood of a successful FDA clinical trial of such molecule's safety and efficacy, including potential side effects and toxicity, and, if potential deficiencies are identified, the use of such artificial intelligence to assist in the tailoring of such clinical trials in order to remedy such deficiencies; includes the circumstance in which a clinical trial has already been performed unsuccessfully, the revision of the clinical trial protocol to remedy the deficiency.
Owner
- GATC Health Corp, Irvine, CA, US
Prosecution history
- 18 Mar 2026 — NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
- 18 Mar 2026 — ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
- 18 Mar 2026 — ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
- 26 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Feb 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 23 Jan 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 23 Jan 2026 — FINAL REFUSAL E-MAILED
- 23 Jan 2026 — FINAL REFUSAL WRITTEN
- 05 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Dec 2025 — NON-FINAL ACTION E-MAILED
- 23 Dec 2025 — NON-FINAL ACTION WRITTEN